Question to the Department for Business and Trade:

To ask the Secretary of State for Business and Trade, pursuant to the answer of 10 December 2025 to Question 97685, whether any additional commitments have been made by the UK in relation to UK-US agreement on pharmaceutical in addition to the increased spending on innovative medicines and the cap on VPAG rates.

The UK has secured a zero percent tariff on all pharmaceuticals exported to the US - the lowest rate offered to any country. We have also secured preferential terms for the UK’s medical technology exports for three years, meaning no additional new tariffs on medical technologies.

This agreement was supported by the government’s commitment to investing 25% more in new innovative medicines – the first major increase in over two decades – which will support improved access to new medicines for NHS patients.

Further work to finalise underpinning details is ongoing. We will share more information when we are able to.